{"id":21848,"date":"2023-09-07T20:00:00","date_gmt":"2023-09-07T20:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4200112_CN00112_0"},"modified":"2023-09-07T20:00:00","modified_gmt":"2023-09-07T20:00:00","slug":"world-orphan-drug-alliance-welcomes-specialised-therapeutics","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=21848","title":{"rendered":"World Orphan Drug Alliance Welcomes Specialised Therapeutics"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li><b><i>SEA&#8217;s largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases<span id=\"spanHghlt44b8\">.<\/span><\/i><\/b><\/li>\n<li><b><i>ST to represent WODA in <span class=\"xn-location\">Australia<\/span>, <span class=\"xn-location\">New Zealand<\/span> and across <span class=\"xn-location\">Southeast Asia<\/span> (ANZSEA)<span id=\"spanHghlta6eb\">.<\/span><\/i><\/b><\/li>\n<li><b><i>World Orphan Drug Alliance (WODA) now spans 152 countries.<\/i><\/b><\/li>\n<li><b><i>WODA offers a &#8216;one-stop&#8217; solution for biotech companies seeking to commercialise products across global markets.<\/i><\/b><\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SINGAPORE<\/span> and <span class=\"xn-location\">PRINCETON, N.J.<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Sept. 8, 2023<\/span><\/span> \/PRNewswire\/ &#8212; Independent biopharmaceutical company Specialised Therapeutics (ST) has joined World Orphan Drug Alliance (WODA), an international consortium of pharmaceutical companies, established to improve patient access to new treatments for rare diseases.<\/p>\n<p>WODA operates by identifying biotech and pharmaceutical companies with new therapies for treating rare diseases that may not be available to patients in many regions and providing these companies with the opportunity to commercialise their novel therapies in member countries.<\/p>\n<p>WODA Chairman <span class=\"xn-person\">Patrick Jordan<\/span> commented:<i> &#8220;It&#8217;s truly inspiring and exciting to witness the alliance&#8217;s expansion. WODA&#8217;s commercial presence has now extended to an impressive number of 152 markets covered by nine like-minded pharmaceutical companies, providing extensive global outreach with a local focus. Our members are experienced and high-performance commercialisation companies, each being an expert in their own region.&#8221;<\/i><\/p>\n<p>He added:<i> &#8220;Through seamless collaboration among our members, we provide our partners with a single platform for full commercialisation of medicines, tailored to both partner and product needs.&#8221;<\/i><\/p>\n<p>Specialised Therapeutics CEO <span class=\"xn-person\">Carlo Montagner<\/span> said WODA&#8217;s mission to address the unmet medical needs of local communities with novel therapies strongly aligned with ST&#8217;s vision.<\/p>\n<p><i>&#8220;We firmly believe that patients in our regions should have access to the same innovative treatments as patients have in larger markets like the US and <span class=\"xn-location\">Europe<\/span>,&#8221; <\/i>Mr. Montagner commented.<\/p>\n<p><i>&#8220;We now look forward to working with our WODA peers to ensure timely and equitable access to new therapies that may improve outcomes. I am confident that our WODA membership will further expand our capabilities, enabling us to provide additional therapies where there is an unmet need.&#8221;<\/i><\/p>\n<p><b>About Specialised Therapeutics<\/b><\/p>\n<p>Founded in 2007, Specialised Therapeutics is the region&#8217;s largest independent specialty pharmaceutical company, providing new therapies and technologies to patients in <span class=\"xn-location\">Australia<\/span>, <span class=\"xn-location\">New Zealand<\/span> and across <span class=\"xn-location\">Southeast Asia<\/span>. Headquartered in <span class=\"xn-location\">Singapore<\/span>, ST partners with global pharmaceutical, biotech and diagnostic companies to bring novel healthcare opportunities to patients who are impacted by a range of diseases. ST has built a strong track record of success, navigating complex regulatory, reimbursement and commercialisation environments in its diverse regions. The ST mission is to provide specialty therapies where there is an unmet need. The company&#8217;s broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, ophthalmology and supportive care, although it is not confined to these areas.<\/p>\n<p>Additional information: <a href=\"http:\/\/www.stbiopharma.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><b>www.stbiopharma.com<\/b><\/a>&nbsp;<\/p>\n<p><b>About WODA<\/b><\/p>\n<p>The World Orphan Drug Alliance (WODA) is a global alliance of commercial distributors focused on providing access to treatments for rare diseases and specialty medicines in complex and underserved markets around the world. WODA aims to provide comprehensive support to pharmaceutical and biotech companies with rare disease, oncology, and highly specialized therapeutics portfolio, starting from Named Patient Programs through to full commercialization.&nbsp;<\/p>\n<p>Additional information<b>: <a href=\"http:\/\/www.woda-alliance.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.woda-alliance.com<\/a>&nbsp;<\/b><\/p>\n<p><b>About other WODA members<\/b><\/p>\n<ul type=\"disc\">\n<li><b><a href=\"https:\/\/www.effrx.com\/\" target=\"_blank\" rel=\"nofollow noopener\">EffRx Pharmaceuticals<\/a><\/b>&nbsp;is a <span class=\"xn-location\">Switzerland<\/span> based company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications.<\/li>\n<li><b><a href=\"http:\/\/www.medis.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Medis<\/a><\/b>&nbsp;based in <span class=\"xn-location\">Slovenia<\/span> is the commercialization partner of choice for innovative pharmaceutical and biotech companies seeking strong business growth in Central and <span class=\"xn-location\">Eastern Europe<\/span>.<\/li>\n<li><b><a href=\"https:\/\/orpharm.net\/\" target=\"_blank\" rel=\"nofollow noopener\">Orpharm<\/a><\/b>&nbsp;is a <span class=\"xn-location\">Moscow<\/span> based full-service distributor covering <span class=\"xn-location\">Russia<\/span> and the Commonwealth of Independent States (CIS).<\/li>\n<li><b><a href=\"https:\/\/www.orphandc.com\/\" target=\"_blank\" rel=\"nofollow noopener\">OrphanDC<\/a> G<\/b> based in <span class=\"xn-location\">Brazil<\/span> acts as a partner for biotech companies in <span class=\"xn-location\">Latin America<\/span>. They focus on supporting their clients from the clinical development stage throughout the product lifecycle.<\/li>\n<li><b><a href=\"https:\/\/vectorpharma.me\/\" target=\"_blank\" rel=\"nofollow noopener\">Vector Pharma<\/a><\/b>&nbsp;is a <span><span class=\"xn-location\">Dubai<\/span><\/span> based full-service distributor covering <span class=\"xn-location\">Middle East<\/span>, <span class=\"xn-location\">North Africa<\/span> and <span class=\"xn-location\">Turkey<\/span>.<\/li>\n<li>The <span class=\"xn-location\">Greater China<\/span> region is covered by <a href=\"http:\/\/www.rarestonegroup.com\/en\/\" target=\"_blank\" rel=\"nofollow noopener\">RareStone Group<\/a>, which aims to become the leading company supporting the rare disease community in <span class=\"xn-location\">China<\/span>.<\/li>\n<li>Founded in 1921, <a href=\"https:\/\/eng.cts.co.il\/?CategoryID=241&amp;ArticleID=231\" target=\"_blank\" rel=\"nofollow noopener\">CTS<\/a>&nbsp;is among <span class=\"xn-location\">Israel&#8217;s<\/span> leading pharmaceutical companies and is well-known for its strong capabilities in local access, distribution, and marketing of high-end therapies.<\/li>\n<li><a href=\"https:\/\/path-pharma.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Path Pharma<\/a>&nbsp;is a full-service distributor in <span class=\"xn-location\">Greece<\/span>, <span class=\"xn-location\">Cyprus<\/span>, and <span class=\"xn-location\">Malta<\/span>. Founded by industry experts, Path Pharma has expertise in local market access, medical support, and marketing and sales, with focus on rare diseases, highly specialized therapeutics, and oncology.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>SEA&#8217;s largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). World Orphan Drug Alliance (WODA) now spans 152 countries. WODA offers a &#8216;one-stop&#8217; solution for biotech companies [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-21848","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=21848\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog\" \/>\n<meta property=\"og:description\" content=\"SEA&#8217;s largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). World Orphan Drug Alliance (WODA) now spans 152 countries. WODA offers a &#8216;one-stop&#8217; solution for biotech companies [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=21848\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-07T20:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"World Orphan Drug Alliance Welcomes Specialised Therapeutics\",\"datePublished\":\"2023-09-07T20:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848\"},\"wordCount\":731,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2202786\\\/combined_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848\",\"name\":\"World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2202786\\\/combined_Logo.jpg?p=medium600\",\"datePublished\":\"2023-09-07T20:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2202786\\\/combined_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2202786\\\/combined_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21848#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"World Orphan Drug Alliance Welcomes Specialised Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=21848","og_locale":"en_US","og_type":"article","og_title":"World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog","og_description":"SEA&#8217;s largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). World Orphan Drug Alliance (WODA) now spans 152 countries. WODA offers a &#8216;one-stop&#8217; solution for biotech companies [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=21848","og_site_name":"My Blog","article_published_time":"2023-09-07T20:00:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=21848#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"World Orphan Drug Alliance Welcomes Specialised Therapeutics","datePublished":"2023-09-07T20:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848"},"wordCount":731,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=21848","url":"https:\/\/transmediavictoria.net.au\/?p=21848","name":"World Orphan Drug Alliance Welcomes Specialised Therapeutics - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600","datePublished":"2023-09-07T20:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21848#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=21848"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=21848#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2202786\/combined_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=21848#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"World Orphan Drug Alliance Welcomes Specialised Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/21848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21848"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/21848\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}